On March 18, 2024, SymBio Pharmaceuticals Limited closed the transaction. The company amended the terms of the transaction and issued 1,350,000 common shares at an issue price of ¥190 per share for the gross proceeds of ¥256,500,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
181 JPY | +4.02% |
|
+9.70% | -26.72% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.72% | 51.61M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- 4582 Stock
- News SymBio Pharmaceuticals Limited
- SymBio Pharmaceuticals Limited amended terms of the transaction